Range Low Price High Price Comment
30 days $27.00 $36.72 Wednesday, 27th Mar 2024 ARWR stock ended at $28.70. This is 3.09% more than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 3.63% from a day low at $27.86 to a day high of $28.87.
90 days $27.00 $39.83
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
2020-07-22 $48.75 $49.65 $47.36 $48.60 765 700
2020-07-21 $51.75 $52.00 $48.42 $48.75 1 061 300
2020-07-20 $49.13 $51.54 $48.76 $51.27 1 175 100
2020-07-17 $48.88 $49.99 $48.72 $49.02 822 000
2020-07-16 $47.98 $49.31 $47.44 $49.02 768 000
2020-07-15 $48.09 $48.75 $47.18 $48.18 894 200
2020-07-14 $46.11 $47.39 $45.20 $47.34 1 459 300
2020-07-13 $45.00 $48.97 $44.70 $46.13 1 816 600
2020-07-10 $45.28 $45.85 $44.42 $44.51 721 900
2020-07-09 $45.30 $46.27 $44.34 $45.15 1 034 800
2020-07-08 $44.63 $45.31 $44.25 $45.25 746 500
2020-07-07 $43.69 $45.72 $43.15 $44.24 926 300
2020-07-06 $44.54 $45.16 $43.49 $43.72 816 900
2020-07-02 $44.62 $45.20 $43.00 $44.20 945 967
2020-07-01 $43.20 $44.80 $42.94 $44.16 1 244 504
2020-06-30 $42.61 $43.41 $41.34 $43.19 965 088
2020-06-29 $43.28 $43.54 $42.03 $42.60 1 086 429
2020-06-26 $42.00 $43.84 $41.34 $43.27 2 091 402
2020-06-25 $39.39 $42.39 $38.31 $42.23 1 230 268
2020-06-24 $41.48 $42.21 $39.03 $39.76 1 342 070
2020-06-23 $40.08 $42.97 $39.83 $41.76 2 064 473
2020-06-22 $36.49 $40.02 $35.64 $39.83 1 401 209
2020-06-19 $36.91 $37.14 $35.54 $36.73 2 739 314
2020-06-18 $35.48 $37.62 $35.24 $36.72 947 399
2020-06-17 $35.86 $36.24 $34.65 $35.51 975 259
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT